Martin Osborn has over 22+ years of biopharmaceutical experience including positions of national leadership, digital transformation, R&D, commercial strategy, communications, and operational excellence aligned to achieve a $30B+ quota in the Fortune 500. He has effectively used these skills and experiences to achieve quota and drive commercial sales and marketing innovation. 

Currently, Osborn leads a team of talented individuals focused on a consultative partnership to apply disruptive, digital capabilities to win business with proven best practices for the entire U.S. market region of the Medtronic enterprise. He also acts as a venture capital and new technology startup industry consultant and has participated in multiple public speaking engagements covering new sales enablement technology and trends in operational excellence. Osborn considers himself an "equity broker" focused on the value of diversity and inclusion in the workplace and world.